Workflow
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of 0.16pershare,beatingtheZacksConsensusEstimateof0.16 per share, beating the Zacks Consensus Estimate of 0.08 per share. This compares to loss of 0.03pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof1000.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this biotechnology company would post earnings of 0.03 per share when it actually produced earnings of $0.09, delivering a surprise of 200%.Over the last four quarters ...